Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
002582 Haoxiangni Health Food
- 8.76
- +0.48+5.80%
Not Open Dec 12 15:00 CST
3.96BMarket Cap-55.09P/E (TTM)
8.99High7.90Low803.33KlotVolume8.12Open8.28Pre Close680.63MTurnover23.34%Turnover RatioLossP/E (Static)452.26MShares9.2352wk High1.11P/B3.01BFloat Cap3.7452wk Low9.11Limit Up344.12MShs Float19.88Historical High7.45Limit Down13.16%Amplitude3.61Historical Low1.00Dividend TTM8.47Avg Price354.47KlotAsk11.42%Div YieldTTM100Lot Size418.10KlotBid
Haoxiangni Health Food Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -27.99%1.18B | -8.55%1.35B | 10.37%1.66B | 12.75%1.44B | 27.86%1.63B | 6.64%1.47B | -10.06%1.5B | -25.58%1.28B | -24.64%1.28B | -21.24%1.38B |
| Transactional financial assets | -22.15%386.37M | -12.65%386.74M | -5.86%401.55M | -32.57%376.03M | -22.78%496.28M | -32.52%442.74M | -29.44%426.53M | -0.30%557.64M | -22.74%642.65M | -22.37%656.07M |
| Notes receivable and accounts receivable | 8.53%91.23M | 26.21%74.81M | 28.42%88.2M | -5.64%108.05M | -23.45%84.06M | -32.58%59.27M | -1.27%68.68M | 18.65%114.51M | 63.20%109.8M | 30.63%87.92M |
| -Notes receivable | -12.83%655.16K | 469.70%1.48M | 77.59%1.04M | 910.49%1.31M | 478.82%751.6K | 420.00%260K | 1,075.77%587.89K | 53.01%129.85K | 53.01%129.85K | --50K |
| -Accounts receivable | 8.72%90.57M | 24.26%73.33M | 27.99%87.16M | -6.68%106.74M | -24.04%83.31M | -32.84%59.01M | -2.04%68.1M | 18.62%114.38M | 63.21%109.67M | 30.55%87.87M |
| Other receivables (including interest and dividends) | 13.27%19.83M | 10.83%19.91M | 20.51%35.49M | -22.04%29.09M | -47.77%17.5M | -39.15%17.97M | 6.36%29.45M | 23.25%37.31M | -35.18%33.51M | -29.92%29.53M |
| -Dividend receivable | ---- | ---- | ---- | --9.02M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other receivable | ---- | 10.83%19.91M | ---- | ---- | ---- | -39.15%17.97M | ---- | 23.25%37.31M | ---- | -19.66%29.53M |
| Advance payment | -20.28%12.26M | -22.68%10.15M | 72.33%34.37M | -67.40%10.69M | -48.31%15.38M | -64.82%13.13M | -59.47%19.94M | 64.62%32.78M | -23.28%29.74M | -1.83%37.31M |
| Inventories | -44.29%248.39M | -29.59%341.17M | -37.61%343.81M | -32.72%424.36M | -39.67%445.86M | -1.94%484.55M | 6.19%551.04M | 4.74%630.76M | 140.35%739.03M | 65.28%494.12M |
| Assets held for sale | ---- | --203.54K | ---- | ---- | ---- | ---- | ---- | --478.84K | ---- | ---- |
| Non-current assets due within one year | 23.00%2.26M | -2.40%2.26M | -2.76%2.26M | -0.37%2.45M | -87.62%1.84M | -83.57%2.32M | -81.46%2.33M | -78.03%2.45M | -13.83%14.87M | -13.40%14.12M |
| Other current assets | -64.10%13.81M | -52.62%20.6M | -58.29%20.06M | -56.62%22.96M | -40.93%38.48M | -12.55%43.48M | -14.25%48.1M | -23.02%52.94M | 9.75%65.15M | -13.45%49.73M |
| Total current assets | -28.63%1.95B | -13.15%2.2B | -2.43%2.58B | -10.81%2.41B | -6.17%2.73B | -7.78%2.53B | -11.98%2.65B | -12.83%2.71B | -5.09%2.91B | -11.82%2.75B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M | 0.00%28.62M |
| Other non-current financial assets | -51.12%325.47M | -51.38%321.97M | -49.10%327.35M | 6.66%675.85M | 2.86%665.85M | 6.74%662.17M | 22.01%643.16M | 23.18%633.62M | 41.18%647.31M | 40.97%620.35M |
| Investment real estate | -4.78%148.28M | -4.70%150.42M | -5.31%151.47M | -5.24%153.59M | -15.53%155.72M | 148.81%157.84M | 148.04%159.96M | 147.29%162.08M | 176.80%184.34M | -6.23%63.44M |
| Long-term equity investment | 232.25%1.03B | 232.44%1.03B | 230.39%1.02B | 228.64%1.01B | 0.40%308.98M | 0.85%309.19M | 1.41%309.32M | 1.12%308M | 0.62%307.75M | -0.18%306.57M |
| Long term receivable account | -79.07%280.19K | -55.83%280.19K | -55.83%280.19K | 11.02%704.15K | 39.07%1.34M | -68.17%634.28K | -82.15%634.28K | -87.64%634.28K | -88.88%962.41K | -80.87%1.99M |
| Fixed assets | ---- | -7.06%867.19M | ---- | ---- | ---- | -9.27%933.07M | ---- | -8.96%978.44M | ---- | -4.91%1.03B |
| Fixed assets liquidation | ---- | -97.76%8.93K | ---- | ---- | ---- | 3,083.46%397.69K | ---- | ---- | ---- | --12.49K |
| Constru in process | ---- | 454.98%43.14M | ---- | ---- | ---- | -93.10%7.77M | ---- | -98.73%1.32M | ---- | -17.23%112.67M |
| Productive biological assets | -2.49%7.98M | -6.93%7.74M | -5.51%7.91M | -5.42%8.05M | -5.32%8.18M | -5.23%8.32M | -6.03%8.37M | -5.94%8.51M | -5.73%8.64M | -5.61%8.78M |
| Intangible assets | -2.82%111.68M | -2.79%112.72M | -2.70%113.84M | -2.73%114.82M | -3.50%114.92M | -3.45%115.96M | -3.39%117.01M | -2.09%118.04M | -1.81%119.09M | -1.77%120.1M |
| Long deferred expense | -4.46%41.86M | -1.34%44.75M | -0.18%48.41M | 2.52%52.02M | -18.42%43.81M | -16.28%45.36M | -13.90%48.5M | -11.91%50.74M | 126.36%53.7M | 117.17%54.18M |
| Deferred tax assets | 9.18%88.8M | 15.70%90.65M | 10.31%80.41M | -2.44%86.98M | 43.25%81.34M | 49.56%78.35M | 55.16%72.89M | 88.90%89.16M | 42.77%56.78M | 53.02%52.39M |
| Usufruct assets | -28.33%39.9M | -18.13%47.14M | -22.53%48.37M | -20.60%52.63M | -21.70%55.67M | -29.15%57.57M | -17.11%62.44M | -4.25%66.28M | 21.89%71.1M | 97.23%81.26M |
| Other non current assets | -3.94%111.99M | 2.55%114.91M | 1.05%112.82M | 26.25%112.62M | 93.04%116.58M | 113.79%112.06M | 8,339.20%111.65M | 5,335.88%89.21M | 3,417.07%60.39M | 590.30%52.41M |
| Total non current assets | 13.05%2.84B | 13.51%2.86B | 13.20%2.85B | 26.60%3.21B | -1.40%2.51B | -0.55%2.52B | 5.07%2.52B | 5.51%2.53B | 8.77%2.55B | 9.53%2.53B |
| Total assets | -8.65%4.79B | 0.13%5.06B | 5.19%5.44B | 7.28%5.62B | -3.94%5.25B | -4.31%5.05B | -4.41%5.17B | -4.83%5.24B | 0.91%5.46B | -2.73%5.28B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -19.94%80.06M | 54.99%155.13M | 55.00%155.14M | -40.00%150.14M | -71.43%100M | -59.98%100.09M | -69.96%100.09M | -24.74%250.25M | -27.36%350M | -48.10%250.09M |
| Transactional financial liabilities | --686.96K | --394.55K | --159.49K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | -21.42%96.41M | -0.99%80.77M | -16.16%73.65M | 1.58%138.59M | 6.74%122.69M | 53.32%81.58M | 60.37%87.85M | -2.73%136.44M | 16.37%114.93M | -40.86%53.21M |
| -Notes payable | 33.70%6.5M | 10.49%10.74M | 46.50%14.24M | 20.20%8.36M | -30.11%4.86M | --9.72M | --9.72M | --6.96M | --6.96M | ---- |
| -Accounts payable | -23.69%89.91M | -2.54%70.03M | -23.96%59.41M | 0.58%130.23M | 9.12%117.82M | 35.05%71.86M | 42.63%78.14M | -7.69%129.49M | 9.32%107.98M | -40.86%53.21M |
| Contract liabilities | 11.51%57.04M | 42.31%72.18M | 102.71%107.06M | 109.72%132.69M | -1.42%51.16M | 0.50%50.72M | 2.79%52.82M | 1.41%63.27M | -21.14%51.89M | -5.21%50.46M |
| Advance receipts | -67.52%327.61K | -68.13%355.87K | -84.34%107.68K | -4.18%587.57K | -2.40%1.01M | 5.30%1.12M | 2.90%687.59K | -39.16%613.21K | -18.06%1.03M | -35.79%1.06M |
| Salaries payable | -14.13%24.51M | -2.39%20.94M | -11.87%20.01M | 19.23%34.35M | 1.98%28.55M | 1.53%21.46M | 15.37%22.71M | 12.75%28.81M | 46.49%27.99M | 29.44%21.13M |
| Taxs payable | -35.53%10.48M | -27.05%4.67M | -42.49%5.81M | -10.76%8.58M | 97.16%16.26M | -10.15%6.4M | 63.35%10.1M | 16.07%9.61M | 63.60%8.25M | 46.91%7.12M |
| Other payable (including interest and dividends) | -20.24%48.96M | 103.57%67.03M | 105.57%84.31M | 123.60%65.75M | 96.25%61.39M | -33.64%32.93M | -3.74%41.01M | -22.55%29.41M | -36.73%31.28M | -2.90%49.62M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | --510.5K | --510.5K | --510.5K | --510.5K |
| -Other payable | ---- | 103.57%67.03M | ---- | ---- | ---- | -32.95%32.93M | ---- | -23.89%28.9M | ---- | -3.90%49.11M |
| Non current liabilities due within one year | 146.18%340.83M | 160.33%341.47M | 138.70%327.95M | 87.25%229.11M | 24.35%138.45M | 17.20%131.16M | 499.70%137.39M | 79.48%122.35M | --111.33M | --111.91M |
| Other current liabilities | 11.44%5.91M | 12.28%5.79M | 5.35%5.46M | -1.66%6.48M | -1.45%5.31M | -2.60%5.16M | -0.59%5.18M | 4.76%6.59M | -17.46%5.38M | -1.22%5.29M |
| Total current liabilities | 26.76%665.23M | 73.88%748.72M | 70.29%779.66M | 18.37%766.28M | -25.25%524.8M | -21.69%430.6M | -14.68%457.85M | -5.14%647.34M | -3.53%702.1M | -21.92%549.9M |
| Current liabilities | ||||||||||
| Long term loan | -3.78%351.22M | 28.88%315.76M | 41.73%354.32M | 299.34%499.67M | 151.74%365.03M | 444.44%245M | 66.67%250M | 24.93%125.12M | --145M | --45M |
| Long term account payable | ---- | -56.92%918K | ---- | ---- | ---- | -38.84%2.13M | ---- | 13.96%3.5M | ---- | 15.54%3.48M |
| Deferred tax liabilities | 18.87%45.38M | 20.78%46.9M | -5.92%37.08M | 4.09%51.22M | -6.08%38.17M | -19.78%38.83M | 6.51%39.41M | 17.76%49.21M | 56.26%40.65M | 61.43%48.41M |
| Long term deferred income | -9.14%163.55M | -9.24%167.12M | -9.64%171.46M | -9.25%175.6M | -8.94%180M | -5.82%184.13M | -4.81%189.75M | -5.32%193.49M | -6.16%197.66M | -12.64%195.51M |
| Lease liabilities | -43.47%15.91M | 22.60%32.49M | -17.86%23.6M | -20.26%25.54M | -21.34%28.15M | -39.06%26.5M | -19.70%28.73M | -10.79%32.03M | -25.22%35.78M | 36.08%43.48M |
| Other non current liabilities | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K | 0.00%436.37K |
| Total non current liabilities | -6.09%576.52M | 13.40%563.63M | 15.16%587.84M | 86.89%754.66M | 45.13%613.92M | 47.78%497.03M | 19.81%510.46M | 4.68%403.79M | 46.89%423.01M | 16.29%336.32M |
| Total liabilities | 9.05%1.24B | 41.47%1.31B | 41.23%1.37B | 44.70%1.52B | 1.21%1.14B | 4.67%927.63M | 0.59%968.3M | -1.60%1.05B | 10.77%1.13B | -10.80%886.22M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.44%453.24M | 2.26%453.24M | 2.26%453.24M | 2.26%453.24M | -1.25%451.26M | -3.01%443.24M | -3.01%443.24M | -3.01%443.24M | 0.00%456.98M | -11.38%456.98M |
| Capital reserve funds | 1.91%1.59B | 3.58%1.58B | 3.20%1.58B | 2.70%1.57B | -4.57%1.56B | -6.27%1.53B | -6.28%1.53B | -6.28%1.53B | 0.00%1.63B | -26.85%1.63B |
| Surplus reserve funds | 0.00%316.95M | 0.00%316.95M | -0.00%316.95M | 0.00%316.95M | 0.00%316.95M | 0.00%316.95M | 0.00%316.96M | 0.00%316.95M | 0.00%316.95M | 0.00%316.95M |
| Retained profit | -27.81%1.33B | -18.00%1.53B | -5.00%1.84B | -5.00%1.83B | -10.74%1.84B | -12.02%1.86B | -10.62%1.94B | -10.88%1.93B | -2.57%2.06B | -1.65%2.12B |
| Less:Treasury stock | 235.84%105.89M | --105.79M | --89.55M | --39.33M | -72.86%31.53M | ---- | ---- | ---- | 0.00%116.17M | -84.98%116.17M |
| Shareholders equity without minority interests | -13.42%3.58B | -9.07%3.78B | -3.02%4.1B | -2.00%4.13B | -4.99%4.13B | -5.77%4.15B | -5.17%4.23B | -5.28%4.21B | -1.24%4.35B | -0.80%4.41B |
| Minority interests | -8.35%-29.32M | -4.90%-29.73M | -13.39%-29.31M | -15.60%-28.82M | -79.36%-27.06M | -106.98%-28.34M | -118.98%-25.85M | -121.47%-24.93M | -57.56%-15.08M | -67.46%-13.69M |
| Total shareholder equity | -13.56%3.55B | -9.16%3.75B | -3.12%4.07B | -2.11%4.1B | -5.28%4.11B | -6.12%4.12B | -5.50%4.2B | -5.60%4.19B | -1.37%4.34B | -0.93%4.39B |
| Total liabilityies and equity | -8.65%4.79B | 0.13%5.06B | 5.19%5.44B | 7.28%5.62B | -3.94%5.25B | -4.31%5.05B | -4.41%5.17B | -4.83%5.24B | 0.91%5.46B | -2.73%5.28B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
